|
Name |
Undecyl acetate
|
Molecular Formula | C13H26O2 | |
IUPAC Name* |
undecyl acetate
|
|
SMILES |
CCCCCCCCCCCOC(=O)C
|
|
InChI |
InChI=1S/C13H26O2/c1-3-4-5-6-7-8-9-10-11-12-15-13(2)14/h3-12H2,1-2H3
|
|
InChIKey |
CKQGCFFDQIFZFA-UHFFFAOYSA-N
|
|
Synonyms |
Undecyl acetate; 1731-81-3; Undecanyl acetate; 1-Undecanol, acetate; n-Undecyl acetate; 1-Undecanol, 1-acetate; UNDECYLACETATE; Undecyl alcohol, acetate; Acetic acid undecyl ester; 70Z4PZ8M0S; NSC-23056; UNII-70Z4PZ8M0S; EINECS 217-051-1; AI3-24138; 1-UNDECYL ACETATE; 1-UNDECANOL ACETATE; AMY037; SCHEMBL1300652; CHEMBL2228459; DTXSID80169523; CHEBI:180116; NSC23056; ZINC1848558; LMFA07010220; MFCD00056189; NSC 23056; AKOS024319538; s11867; DB-043925; FT-0633800; BIS(ETHYLENEDIAMINE)PLATINUM(II)CHLORIDE; Q27265902
|
|
CAS | 1731-81-3 | |
PubChem CID | 15605 | |
ChEMBL ID | CHEMBL2228459 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 214.34 | ALogp: | 5.0 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 11 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 15 | QED Weighted: | 0.389 |
Caco-2 Permeability: | -4.61 | MDCK Permeability: | 0.00002310 |
Pgp-inhibitor: | 0.09 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.993 |
30% Bioavailability (F30%): | 0.998 |
Blood-Brain-Barrier Penetration (BBB): | 0.881 | Plasma Protein Binding (PPB): | 94.56% |
Volume Distribution (VD): | 1.115 | Fu: | 6.72% |
CYP1A2-inhibitor: | 0.956 | CYP1A2-substrate: | 0.223 |
CYP2C19-inhibitor: | 0.676 | CYP2C19-substrate: | 0.115 |
CYP2C9-inhibitor: | 0.378 | CYP2C9-substrate: | 0.796 |
CYP2D6-inhibitor: | 0.072 | CYP2D6-substrate: | 0.073 |
CYP3A4-inhibitor: | 0.207 | CYP3A4-substrate: | 0.112 |
Clearance (CL): | 3.346 | Half-life (T1/2): | 0.356 |
hERG Blockers: | 0.147 | Human Hepatotoxicity (H-HT): | 0.011 |
Drug-inuced Liver Injury (DILI): | 0.403 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.027 | Maximum Recommended Daily Dose: | 0.01 |
Skin Sensitization: | 0.938 | Carcinogencity: | 0.102 |
Eye Corrosion: | 0.98 | Eye Irritation: | 0.986 |
Respiratory Toxicity: | 0.579 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000424 | 0.737 | D05ATI | 0.589 | ||||
ENC000399 | 0.723 | D0Z5SM | 0.524 | ||||
ENC001257 | 0.698 | D07ILQ | 0.457 | ||||
ENC000260 | 0.680 | D0AY9Q | 0.424 | ||||
ENC001152 | 0.661 | D0O1PH | 0.421 | ||||
ENC000556 | 0.660 | D00FGR | 0.410 | ||||
ENC000102 | 0.653 | D05QNO | 0.406 | ||||
ENC000472 | 0.653 | D0XN8C | 0.384 | ||||
ENC000272 | 0.652 | D0Y8DP | 0.383 | ||||
ENC000742 | 0.647 | D0Z5BC | 0.368 |